In spite of this record, an FDA advisory panel voted 5-4 against approving the drug for breast cancer. While studies have shown that Avastin shrinks breast tumors, there is no evidence that it lengthens or improves the quality of patients' lives.
FDA Approves Breast Cancer Drug Avastin Despite Opposition by Advisory Panel
Ashley and Kyle were newlyweds in early 2022 and thrilled to be expecting their first child....
More than two years after most abortions became illegal in Alabama, the West Alabama Women’s Center...
A Massachusetts town has ordered its parks to close from dusk to dawn due to a...
